EUVIMEDEUVIMED entdecken
Crossref

Dynamic changes in key factors of the blood-brain barrier in early diabetic mice

Zhi-Yong Xu iD, Shu-Xian Fu, Hui-Chao Zhao, Yin-Min Wang, Yan Liu, Jin-You Ma, Yan Yu, Jia-Le Zhang, Zhan-Peng Han, Ming-Xue Zheng

Journal of Neuropathology & Experimental Neurology · 2024

DOI: 10.1093/jnen/nlae056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2024. Verfasst von Zhi-Yong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology, Xinxiang, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Henan Province Science and Technology, Xinxiang City Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hyperglycemia can result in damage to the hippocampus and dysfunction of the blood-brain barrier (BBB), potentially leading to neurological disorders. This study examined the histological structure of the hippocampus and the expression of critical genes associated with the BBB at 2 early stage time points in a streptozotocin-induced diabetes mellitus (DM) mouse model. Routine histology revealed vascular congestion and dilation of Virchow-Robin spaces in the hippocampal CA1 region of the DM group. Neuronal alterations included rounding and swelling and reduction in Nissl bodies and increased apoptosis. Compared to the control group, TJP1 mRNA expression in the DM group was significantly lower (P < .05 or P < .01), while mRNA levels of JAM3, TJP3, CLDN5, CLDN3, and OCLN initially increased and then decreased. At 7, 14, and 21 days, mRNA levels of the receptor for advanced glycation end products (AGER) were greater in the DM group than in the control group (P < .05 or P < .01). These findings indicate that early-stage diabetes may cause structural and functional impairments in hippocampal CA1 in mice. These abnormalities may parallel alterations in the expression of key BBB tight junction molecules and elevated AGER expression in early DM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierDiabetes Mellitus, ExperimentalAnimalsMiceMaleReceptor for Advanced Glycation End ProductsHippocampus

Stichwörter der Autor:innen

blood-brain barrierearly diabetes mellitushippocampusreceptor for advanced glycation end productstight junction

Substanzen

Receptor for Advanced Glycation End Products

Autor:innen und Institutionen

  • College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology, Xinxiang, China.
  • The 83rd Army Group Hospital of the Chinese People's Liberation Army, Xinxiang, China.
  • College of Veterinary Medicine, Shanxi Agricultural University, Taigu, China.

ORCID-Profile: Zhi-Yong Xu

Förderung

  • Henan Province Science and Technology
  • Xinxiang City Science and Technology

Zitieren

APA

Xu, Z. Y., Fu, S. X., Zhao, H. C., Wang, Y. M., Liu, Y., Ma, J. Y., Yu, Y., Zhang, J. L., Han, Z. P., & Zheng, M. X. (2024). Dynamic changes in key factors of the blood-brain barrier in early diabetic mice. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlae056

Vancouver

Xu ZY, Fu SX, Zhao HC, Wang YM, Liu Y, Ma JY, et al. Dynamic changes in key factors of the blood-brain barrier in early diabetic mice. Journal of Neuropathology & Experimental Neurology. 2024. doi:10.1093/jnen/nlae056

BibTeX
@article{Xu2024,
  author = {Xu, Zhi-Yong and Fu, Shu-Xian and Zhao, Hui-Chao and Wang, Yin-Min and Liu, Yan and Ma, Jin-You and Yu, Yan and Zhang, Jia-Le and Han, Zhan-Peng and Zheng, Ming-Xue},
  title = {Dynamic changes in key factors of the blood-brain barrier in early diabetic mice},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2024},
  doi = {10.1093/jnen/nlae056}
}
Kostenlos starten →